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929, 932, 950, and 959. Cardiovascular disease (CVD) is the leading cause of morbidity andmortality for women in the United States, Canada, and most de-veloped countries. In developing countries it will be the leadingcause of death in the next 20 years. It is a costly disease both interms of health care dollars spent and patient lives. Approximately250,000 women die each year in the United States, and women are
3 times as likely to die of CVD as they are of breast cancer.1 With the publication
10 years ago of 2 sentinel studies detailing the differences between men and women
in the delivery of care to patients with CVD, there has been an increased awareness
in the health care community and the lay public of issues relevant to the assessment
and management of CVD in women.2,3 Perception of CVD by both communities is
still evolving and is often influenced by insufficient or, worse, inaccurate informa-
tion. The androcentric focus of much of cardiovascular research contributes to this
problem. Only recently have women been included in sufficient numbers in clinical
trials and databases or has there been a requirement for sex-based analysis of data
such that specific information pertaining to results in women has been available.3-5
The problem is compounded when trying to analyze the results of coronary artery
bypass grafting (CABG) in women because only 30% of all CABG operations are
performed on women and fewer women than men are referred for operation,
resulting in small sample sizes.6
Numerous studies have demonstrated increased hospital mortality after CABG in
women when compared with men.7-9 Increased mortality in women in these studies
has often been attributed to referral bias, smaller vessels, decreased body size, and
an increased incidence of comorbidities.10-13 More recently, studies suggest that
despite the obvious premorbid differences between men and women, women still
clearly benefit from surgical revascularization.13,14 Despite good long-term results
for women undergoing CABG, misperception of results still clearly influences their
surgical treatment. For example, proportionally fewer women receive arterial grafts
or reoperation.11,13,15,16 We review the intraoperative factors and considerations that
are unique to women facing CABG in an attempt to raise awareness and to support
the use of surgical revascularization in women.
Technical Aspects of CABG
Despite advances in cardiopulmonary bypass and postoperative care that appear to
have reduced perioperative mortality in men, the perioperative mortality after
CABG in women remains twice that of men.17 Women experience a longer time to
diagnosis, treatment, and referral to invasive testing.5,18 Women appear to have
more acute presentations, are 10 years older on presentation, and have multiple
comorbidities when compared with men. One recent editorial suggests that in-
creased perioperative mortality might be related to a higher incidence of left
ventricular hypertrophy and hypertensive heart disease in women.19 However, when
comorbidities are adjusted for by using multivariate models, women still face a
significantly higher operative risk when compared with that faced by men.17
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Therefore there must be some other perioperative variable
that we do not appreciate that accounts for this increased
mortality.
We should therefore consider several intraoperative fac-
tors as they apply to women. The use of cardioplegia and
cardiopulmonary bypass and the administration of cardio-
plegia should be evaluated carefully. A decrease in mortal-
ity and morbidity in women undergoing CABG without
cardiopulmonary bypass has been suggested.20 Mortality in
women undergoing off-pump CABG was equivalent to ex-
pected mortality in men undergoing on-pump CABG in one
study (2.3% for off-pump CABG and 4.1% for on-pump
CABG in women).20 In a recent study of 16,871 consecutive
women undergoing off-pump and on-pump CABG surgery
at 78 hospitals between January 1998 and June 2001, off-
pump CABG in women was associated with a reduction in
mortality and morbidity.21 The reason for the reduction in
mortality in women for off-pump surgery is not easily
determined. It is best determined by means of randomized
controlled comparisons. This study is not likely to be com-
pleted in the near future. Until the cause of increased
perioperative mortality in women is determined, off-pump
revascularization should be an essential option in the sur-
geon’s armamentarium, particularly for women. Optimal
and complete revascularization can easily be accomplished
without cardiopulmonary bypass. The approach to success-
ful off-pump CABG is the same for all cardiac surgeries and
requires planning, patience, and attention to detail.
Women more frequently present or come to the operation
with ongoing ischemia or with acute presentations. It is
important to consider this when determining the optimal
administration of cardioplegia in women who undergo
CABG on pump. In the setting of acute ischemia, warm
induction cardioplegia should be considered, as well as
warm reperfusion. In addition, the use of hemofiltration
during cardiopulmonary bypass should be considered in
women who are more likely to have congestive heart failure
and volume overload preoperatively.
Use of the left internal thoracic artery (LITA) to the left
anterior descending artery (LAD) has clearly been shown to
be superior to use of the saphenous vein to revascularize the
LAD. Even though there is clear benefit, women still re-
ceive fewer LITA grafts than men, and this choice is not
dependent on the urgency of the operation or the prevalence
of diabetes. The use of radial artery grafting has not been
specifically evaluated in women. Although the use of bilat-
eral internal thoracic artery grafts has been demonstrated to
be safe in women, the benefit of bilateral internal thoracic
artery use compared with a single internal thoracic artery
has not been documented.22 Women should receive a LITA
graft to the LAD and use of the radial artery as first choices
of conduit, as well as attempts to make surgical revascular-
ization complete, to gain the same benefit from CABG as
their male counterparts.
Numerous studies have cited smaller coronary artery size
and resultant increased technical challenge as the major
factor responsible for increased mortality in women under-
going CABG.23 There is no doubt that women have smaller
body surface areas and coronary sizes, as has been demon-
strated by many investigators.24 There are 2 arguments that
suggest that smaller coronary size is not the major factor
responsible for increased mortality in women. The first is
that in the data available, mortality for women who undergo
off-pump CABG is equivalent to that of men. If women
have smaller coronary arteries, then off-pump CABG would
be that much more technically challenging. Therefore off-
pump CABG mortality would intuitively be much higher in
women, which is not the case. The second is that the
mortality in women undergoing CABG decreases with ag-
ing. The mortality difference between men and women is
greatest in the age range of less than 50 years, and in older
women mortality is equivalent to that of men.17 Obviously,
coronary arteries do not get larger with age. Therefore small
coronary artery size cannot be the major factor in the
mortality difference between men and women.
When considering the inability to wean from cardiopul-
monary bypass in women, inotrope use must be weighed
with the use of an intra-aortic balloon pump. Women pose
unique risks to the use of intra-aortic balloon pump because
of smaller body and femoral artery size and an increased
likelihood of having peripheral vascular disease. Smaller
balloon and catheter sizes should obviously be chosen to
reduce the likelihood of complications.
Summary
The bad news is that CVD is the number one killer of
women, and the number of deaths in women has surpassed
that in men since 1984.1 Women do not perceive this threat,
and they might present with atypical symptoms, making
diagnosis difficult. When compared with men, women are
less likely to be referred for invasive testing and less likely
to receive proved efficacious medications (-blockers, as-
pirin, and thrombolytics).5 Women are more likely to
present at an older age (10 years older), to present with
sudden death, and to die from their first myocardial infarc-
tion and are more likely to have multiple comorbidities
when compared with men. The increased operative mortal-
ity noted when women undergo CABG on pump is multi-
factorial and might be related to patient size, comorbidities,
treatment conservatism, and other unknown contributing
factors.
Fortunately, the good news is that women benefit from
surgical revascularization and have similar long-term results
when compared with men. There is hope that equivalent
short-term outcomes can be achieved with the use of off-
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pump CABG. Until the reasons for increased operative
mortality in women are elucidated, we should remain ad-
vocates for public education and awareness and risk factor
modification, include more women in research and clinical
trials, maintain an aggressive approach for women, and
support CABG as a valuable and beneficial treatment op-
tion.
The Use of the Terms “Sex” and “Gender”
When addressing differences between women and men,
every effort should be made to use correct terminology. The
authors of the Institute of Medicine report entitled “Explor-
ing the biological contributions to human health: Does sex
matter?” point out that the interchangeable use of “sex” and
“gender” causes confusion in the scientific community.25
They also note that consistent usage across disciplines
would aid in the accurate measurement and reporting of
differences between men and women. They offer the fol-
lowing recommendations:
1. In the study of human subjects, the term “sex” should
be used as a classification, generally as male or fe-
male, according to the reproductive organs and func-
tions that derive from the chromosomal complement.
2. In the study of human subjects, the term “gender”
should be used to refer to a person’s self-representa-
tion as male or female or how that person is responded
to by social institutions on the basis of the individual’s
gender presentation.
3. In most studies of nonhuman animals, the term “sex”
should be used.
We have attempted to adhere to these recommendations in
this editorial to provide consistency and clarity.
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